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Nowadays thyroid disease found in 50% of the adult population and 80% of the elderly population of Ukraine [1] . To determine the direct cost of health care technologies used for treatment of diffuse toxic goiter in Ukraine.
We made the retrospective analysis of 52 patients's medical records withDTG that were hospitalized to the endocrinology department of Ternopil University Hospital (Jan-Dec 2012). The method of pharmacoeconomic analysis "cost of illness" was used to estimate the cost of health care for patients with DTG. We have made calculations of costs: the cost of laboratory analysis, the cost of instrumental analysis, the cost of drug treatment, doctor's consultations, costs of patient's stay in hospital. While determining the direct costs of medical services in monetary terms we used the rates for medical services that were in Ternopil University Hospital. In the cost structure of health care provision for patients with diffuse toxic goiter the most significant costs were spent for laboratory tests and for patient's stay in hospital. The presence of underlying disease complications significantly increases cost of drugs. The cost of patients stay in hospital
